Alejandra King

2.1k total citations
31 papers, 607 citations indexed

About

Alejandra King is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Alejandra King has authored 31 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 9 papers in Epidemiology and 8 papers in Genetics. Recurrent topics in Alejandra King's work include Immunodeficiency and Autoimmune Disorders (15 papers), Cystic Fibrosis Research Advances (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Alejandra King is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (15 papers), Cystic Fibrosis Research Advances (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Alejandra King collaborates with scholars based in Chile, United States and Colombia. Alejandra King's co-authors include Ricardo U. Sorensen, José Luis Franco, Francisco Espinosa‐Rosales, Antônio Condino‐Neto, Anete Sevciovic Grumach, Liliana Bezrodnik, Lily E. Leiva, Marı́a Elena Santolaya, Beatriz Tavares Costa‐Carvalho and Sean Johnson and has published in prestigious journals such as Nucleic Acids Research, Neurology and Scientific Reports.

In The Last Decade

Alejandra King

31 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandra King Chile 16 200 167 141 126 93 31 607
Beata Wolska‐Kuśnierz Poland 12 315 1.6× 154 0.9× 88 0.6× 69 0.5× 101 1.1× 39 598
Rogier J. L. Stuyt Netherlands 12 301 1.5× 293 1.8× 60 0.4× 155 1.2× 71 0.8× 19 589
Birte Blankenhaus Portugal 12 459 2.3× 213 1.3× 44 0.3× 106 0.8× 144 1.5× 18 839
Berit Brusletto Norway 16 378 1.9× 299 1.8× 40 0.3× 341 2.7× 74 0.8× 36 939
Ana Salinas Spain 15 114 0.6× 423 2.5× 63 0.4× 101 0.8× 82 0.9× 35 800
Vijaya Knight United States 13 179 0.9× 106 0.6× 78 0.6× 163 1.3× 267 2.9× 36 713
J. Toribio Spain 19 104 0.5× 152 0.9× 202 1.4× 336 2.7× 111 1.2× 114 1.1k
Noora Alakulppi Finland 12 152 0.8× 250 1.5× 129 0.9× 152 1.2× 101 1.1× 19 675
Gesmar Rodrigues Silva Segundo Brazil 15 276 1.4× 100 0.6× 122 0.9× 117 0.9× 51 0.5× 52 739
Bruno Daubeuf Switzerland 11 440 2.2× 127 0.8× 34 0.2× 163 1.3× 39 0.4× 20 663

Countries citing papers authored by Alejandra King

Since Specialization
Citations

This map shows the geographic impact of Alejandra King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra King more than expected).

Fields of papers citing papers by Alejandra King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandra King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra King. The network helps show where Alejandra King may publish in the future.

Co-authorship network of co-authors of Alejandra King

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandra King. A scholar is included among the top collaborators of Alejandra King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandra King. Alejandra King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aranda, Carolina Sánchez, Anete Sevciovic Grumach, Gesmar Rodrigues Silva Segundo, et al.. (2024). The Latin American Society for Immunodeficiencies Registry. Journal of Clinical Immunology. 45(1). 28–28. 3 indexed citations
2.
Hoyos‐Bachiloglu, Rodrigo, Arturo Borzutzky, Paula Bustos, et al.. (2020). [Severe combined immunodeficiency, report of chilean patients diagnosed during the 1999-2020 period].. PubMed. 91(6). 908–916. 1 indexed citations
3.
Lacassie, Yves, Britt Johnson, Guillermo Lay‐Son, et al.. (2020). Severe SOPH syndrome due to a novel NBAS mutation in a 27‐year‐old woman—Review of this pleiotropic, autosomal recessive disorder: Mystery solved after two decades. American Journal of Medical Genetics Part A. 182(7). 1767–1775. 8 indexed citations
4.
Lagos, Macarena, Alexander Vargas‐Hernández, Jennifer E. Posey, et al.. (2019). Novel Heterozygous Mutation in NFKB2 Is Associated With Early Onset CVID and a Functional Defect in NK Cells Complicated by Disseminated CMV Infection and Severe Nephrotic Syndrome. Frontiers in Pediatrics. 7. 303–303. 19 indexed citations
5.
6.
Strauss, Kevin A., Claudia Gonzaga‐Jauregui, Karlla W. Brigatti, et al.. (2017). Genomic diagnostics within a medically underserved population: efficacy and implications. Genetics in Medicine. 20(1). 31–41. 36 indexed citations
7.
Jackson, Ryan N., et al.. (2014). The Mtr4 ratchet helix and arch domain both function to promote RNA unwinding. Nucleic Acids Research. 42(22). 13861–13872. 30 indexed citations
8.
Condino‐Neto, Antônio, et al.. (2014). Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID). Allergologia et Immunopathologia. 43(5). 493–497. 9 indexed citations
9.
Valle, Solange Oliveira Rodrigues, Liliana Bezrodnik, Elma Nievas, et al.. (2014). Improving C1 inhibitor deficiency (type 1 and type 2 hereditary angioedema) in Latin America.. PubMed. 24(6). 445–7. 4 indexed citations
10.
Condino‐Neto, Antônio, Anete Sevciovic Grumach, Alejandra King, et al.. (2013). Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America. Allergologia et Immunopathologia. 42(3). 245–260. 17 indexed citations
11.
Costa‐Carvalho, Beatriz Tavares, Anete Sevciovic Grumach, José Luis Franco, et al.. (2013). Attending to Warning Signs of Primary Immunodeficiency Diseases Across the Range of Clinical Practice. Journal of Clinical Immunology. 34(1). 10–22. 57 indexed citations
12.
Condino‐Neto, Antônio, José Luis Franco, Francisco Espinosa‐Rosales, et al.. (2012). Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives. Allergologia et Immunopathologia. 40(3). 187–193. 7 indexed citations
13.
Leiva, Lily E., Liliana Bezrodnik, Matías Oleastro, et al.. (2011). Primary immunodeficiency diseases in Latin America: Proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory Board. Allergologia et Immunopathologia. 39(2). 106–110. 16 indexed citations
14.
Fuente, Miguel Á. de la, Mike Recher, Nicholas L. Rider, et al.. (2011). Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasia. Journal of Allergy and Clinical Immunology. 128(1). 139–146. 27 indexed citations
15.
Condino‐Neto, Antônio, José Luis Franco, Claudia M. Trujillo‐Vargas, et al.. (2010). Critical issues and needs in management of primary immunodeficiency diseases in Latin America. Allergologia et Immunopathologia. 39(1). 45–51. 12 indexed citations
16.
King, Alejandra, et al.. (2009). Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile. Pediatric Blood & Cancer. 53(3). 453–458. 15 indexed citations
17.
Santolaya, Marı́a Elena, Ana Alvarez, Carmen L. Avilés, et al.. (2008). Predictors of Severe Sepsis Not Clinically Apparent During the First Twenty-Four Hours of Hospitalization in Children With Cancer, Neutropenia, and Fever. The Pediatric Infectious Disease Journal. 27(6). 538–543. 58 indexed citations
18.
Yong, Patrick, Frank A. Post, Kimberly Gilmour, et al.. (2008). Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene. Journal of Clinical Pathology. 61(11). 1220–1222. 19 indexed citations
19.
Mead, Simon, Tom Webb, Tracy Campbell, et al.. (2007). Inherited prion disease with 5-OPRI. Neurology. 69(8). 730–738. 48 indexed citations
20.
Campbell, Myriam, et al.. (2005). Establishment of a pediatric HSCT program in a public hospital in Chile. Pediatric Blood & Cancer. 46(7). 803–810. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beata Wolska‐Kuśnierz Breakdown of academic impact, for papers by Rogier J. L. Stuyt Breakdown of academic impact, for papers by Birte Blankenhaus Breakdown of academic impact, for papers by Berit Brusletto Breakdown of academic impact, for papers by Ana Salinas Breakdown of academic impact, for papers by Vijaya Knight Breakdown of academic impact, for papers by J. Toribio Breakdown of academic impact, for papers by Noora Alakulppi Breakdown of academic impact, for papers by Gesmar Rodrigues Silva Segundo Breakdown of academic impact, for papers by Bruno Daubeuf
Rankless by CCL
2026